167 related articles for article (PubMed ID: 26753692)
1. Increased mortality and aggravation of heart failure in liver X receptor-α knockout mice after myocardial infarction.
Liu X; Gao J; Xia Q; Lu T; Wang F
Heart Vessels; 2016 Aug; 31(8):1370-9. PubMed ID: 26753692
[TBL] [Abstract][Full Text] [Related]
2. Activation of liver-X-receptor α but not liver-X-receptor β protects against myocardial ischemia/reperfusion injury.
He Q; Pu J; Yuan A; Lau WB; Gao E; Koch WJ; Ma XL; He B
Circ Heart Fail; 2014 Nov; 7(6):1032-41. PubMed ID: 25277999
[TBL] [Abstract][Full Text] [Related]
3. Clinical aspects of left ventricular diastolic function assessed by Doppler echocardiography following acute myocardial infarction.
Poulsen SH
Dan Med Bull; 2001 Nov; 48(4):199-210. PubMed ID: 11767125
[TBL] [Abstract][Full Text] [Related]
4. Increased mortality and aggravation of heart failure in estrogen receptor-beta knockout mice after myocardial infarction.
Pelzer T; Loza PA; Hu K; Bayer B; Dienesch C; Calvillo L; Couse JF; Korach KS; Neyses L; Ertl G
Circulation; 2005 Mar; 111(12):1492-8. PubMed ID: 15781739
[TBL] [Abstract][Full Text] [Related]
5. Critical role of the NAD(P)H oxidase subunit p47phox for left ventricular remodeling/dysfunction and survival after myocardial infarction.
Doerries C; Grote K; Hilfiker-Kleiner D; Luchtefeld M; Schaefer A; Holland SM; Sorrentino S; Manes C; Schieffer B; Drexler H; Landmesser U
Circ Res; 2007 Mar; 100(6):894-903. PubMed ID: 17332431
[TBL] [Abstract][Full Text] [Related]
6. Deficiency of liver-X-receptor-α reduces glucose uptake and worsens post-myocardial infarction remodeling.
Ji Q; Zhao Y; Yuan A; Pu J; He B
Biochem Biophys Res Commun; 2017 Jul; 488(3):489-495. PubMed ID: 28511797
[TBL] [Abstract][Full Text] [Related]
7. nNOS gene deletion exacerbates pathological left ventricular remodeling and functional deterioration after myocardial infarction.
Dawson D; Lygate CA; Zhang MH; Hulbert K; Neubauer S; Casadei B
Circulation; 2005 Dec; 112(24):3729-37. PubMed ID: 16344403
[TBL] [Abstract][Full Text] [Related]
8. Sphingosine-1-Phosphate Receptor Agonist Fingolimod Increases Myocardial Salvage and Decreases Adverse Postinfarction Left Ventricular Remodeling in a Porcine Model of Ischemia/Reperfusion.
Santos-Gallego CG; Vahl TP; Goliasch G; Picatoste B; Arias T; Ishikawa K; Njerve IU; Sanz J; Narula J; Sengupta PP; Hajjar RJ; Fuster V; Badimon JJ
Circulation; 2016 Mar; 133(10):954-66. PubMed ID: 26826180
[TBL] [Abstract][Full Text] [Related]
9. Absence of type VI collagen paradoxically improves cardiac function, structure, and remodeling after myocardial infarction.
Luther DJ; Thodeti CK; Shamhart PE; Adapala RK; Hodnichak C; Weihrauch D; Bonaldo P; Chilian WM; Meszaros JG
Circ Res; 2012 Mar; 110(6):851-6. PubMed ID: 22343710
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of matrix metalloproteinases improves left ventricular function in mice lacking osteopontin after myocardial infarction.
Krishnamurthy P; Peterson JT; Subramanian V; Singh M; Singh K
Mol Cell Biochem; 2009 Feb; 322(1-2):53-62. PubMed ID: 18979185
[TBL] [Abstract][Full Text] [Related]
11. Borderzone contractile dysfunction is transiently attenuated and left ventricular structural remodeling is markedly reduced following reperfused myocardial infarction in inducible nitric oxide synthase knockout mice.
Gilson WD; Epstein FH; Yang Z; Xu Y; Prasad KM; Toufektsian MC; Laubach VE; French BA
J Am Coll Cardiol; 2007 Oct; 50(18):1799-807. PubMed ID: 17964046
[TBL] [Abstract][Full Text] [Related]
12. Anti-monocyte chemoattractant protein-1 gene therapy attenuates left ventricular remodeling and failure after experimental myocardial infarction.
Hayashidani S; Tsutsui H; Shiomi T; Ikeuchi M; Matsusaka H; Suematsu N; Wen J; Egashira K; Takeshita A
Circulation; 2003 Oct; 108(17):2134-40. PubMed ID: 14517168
[TBL] [Abstract][Full Text] [Related]
13. Cellular FLICE-inhibitory protein protects against cardiac remodelling after myocardial infarction.
Xiao J; Moon M; Yan L; Nian M; Zhang Y; Liu C; Lu J; Guan H; Chen M; Jiang D; Jiang H; Liu PP; Li H
Basic Res Cardiol; 2012 Jan; 107(1):239. PubMed ID: 22202974
[TBL] [Abstract][Full Text] [Related]
14. Mitochondrial cyclophilin-D as a potential therapeutic target for post-myocardial infarction heart failure.
Lim SY; Hausenloy DJ; Arjun S; Price AN; Davidson SM; Lythgoe MF; Yellon DM
J Cell Mol Med; 2011 Nov; 15(11):2443-51. PubMed ID: 21143389
[TBL] [Abstract][Full Text] [Related]
15. Circulating NOS3 modulates left ventricular remodeling following reperfused myocardial infarction.
Gorressen S; Stern M; van de Sandt AM; Cortese-Krott MM; Ohlig J; Rassaf T; Gödecke A; Fischer JW; Heusch G; Merx MW; Kelm M
PLoS One; 2015; 10(4):e0120961. PubMed ID: 25875863
[TBL] [Abstract][Full Text] [Related]
16. Statin-induced improvement of endothelial progenitor cell mobilization, myocardial neovascularization, left ventricular function, and survival after experimental myocardial infarction requires endothelial nitric oxide synthase.
Landmesser U; Engberding N; Bahlmann FH; Schaefer A; Wiencke A; Heineke A; Spiekermann S; Hilfiker-Kleiner D; Templin C; Kotlarz D; Mueller M; Fuchs M; Hornig B; Haller H; Drexler H
Circulation; 2004 Oct; 110(14):1933-9. PubMed ID: 15466656
[TBL] [Abstract][Full Text] [Related]
17. Streptozotocin-induced hyperglycemia exacerbates left ventricular remodeling and failure after experimental myocardial infarction.
Shiomi T; Tsutsui H; Ikeuchi M; Matsusaka H; Hayashidani S; Suematsu N; Wen J; Kubota T; Takeshita A
J Am Coll Cardiol; 2003 Jul; 42(1):165-72. PubMed ID: 12849678
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of glutathione peroxidase prevents left ventricular remodeling and failure after myocardial infarction in mice.
Shiomi T; Tsutsui H; Matsusaka H; Murakami K; Hayashidani S; Ikeuchi M; Wen J; Kubota T; Utsumi H; Takeshita A
Circulation; 2004 Feb; 109(4):544-9. PubMed ID: 14744974
[TBL] [Abstract][Full Text] [Related]
19. Deficiency of ataxia telangiectasia mutated kinase modulates cardiac remodeling following myocardial infarction: involvement in fibrosis and apoptosis.
Foster CR; Daniel LL; Daniels CR; Dalal S; Singh M; Singh K
PLoS One; 2013; 8(12):e83513. PubMed ID: 24358288
[TBL] [Abstract][Full Text] [Related]
20. Antiplatelet therapy mitigates cardiac remodeling and dysfunction in congestive heart failure due to myocardial infarction.
Sanganalmath SK; Barta J; Takeda N; Kumamoto H; Dhalla NS
Can J Physiol Pharmacol; 2008 Apr; 86(4):180-9. PubMed ID: 18418427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
